Severe hypoglycemia is strongly associated with increased risks for a range of adverse clinical outcomes, including macrovascular and microvascular events and death, according to a new study.
Severe hypoglycemia is strongly associated with increased risks for a range of adverse clinical outcomes, including macrovascular and microvascular events and death, according to a study involving more than 11,000 patients with type 2 diabetes mellitus. Whether hypoglycemia is a causal factor or merely a marker of vulnerability to such events remains a mystery.
Australian researchers followed study participants for a median of 5 years. During that time, 231 had at least 1 severe hypoglycemic event; of these, 150 had been assigned to the intensive glucose control cohort, and 81 were in the standard glucose control group. Median times from the onset of severe hypoglycemia to the first major macrovascular event, the first major microvascular event, and death were 1.56 years, 0.99 years, and 1.05 years, respectively.
Compared with those without severe hypoglycemia, patients with the condition were almost 3 times as likely to suffer a major macrovascular event (hazard ratio [HR], 2.88; 95% confidence interval [CI], 2.01-4.12), almost twice as likely to suffer a major microvascular event (HR, 1.81; 95% CI, 1.19-2.74), almost 3 times as likely to die from a cardiovascular cause (HR, 2.68; 95% CI, 1.72-4.19), and almost 3 times as likely to die from any cause (HR, 2.69; 95% CI, 1.97-3.67; P<.001 for all comparisons). The researchers found similar associations for nonvascular conditions, including respiratory, digestive, and skin ailments.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More